Associated Labs/Orgs
Description
"Our reparative biotherapeutics are tailored for disease subtypes diagnosed by biomarkers, pathology and genetics. The biotherapeutics are delivered either by injection or locally by an implantable proprietary gene therapy device to facilitate the most efficient treatment of the disease.”
Funding
$71k
Invasive / Non-invasive / Semi-invasive
Invasive
New/Existing Tech
Tech used (specifics)
encapsulated cell biodelivery (ECB)
Techs Used
ECB
Year Founded
2000